BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29481735)

  • 1. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
    Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
    Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
    Clynes R; Calvani N; Croker BP; Richards HB
    Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
    Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
    Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
    Morse MD; Clark KL; Cascalho M; Kahlenberg JM
    Lupus; 2016 Jan; 25(1):81-7. PubMed ID: 26405027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
    Xiang L; Liu A; Xu G
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus.
    Wang H; Knight JS; Hodgin JB; Wang J; Guo C; Kleiman K; Eitzman DT
    Sci Rep; 2016 Jun; 6():28997. PubMed ID: 27357136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model.
    Correa Freitas E; Evelyn Karnopp T; de Souza Silva JM; Cavalheiro do Espírito Santo R; da Rosa TH; de Oliveira MS; da Costa Gonçalves F; de Oliveira FH; Guilherme Schaefer P; André Monticielo O
    Autoimmunity; 2019 Mar; 52(2):69-77. PubMed ID: 31088305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol possesses protective effects in a pristane-induced lupus mouse model.
    Wang ZL; Luo XF; Li MT; Xu D; Zhou S; Chen HZ; Gao N; Chen Z; Zhang LL; Zeng XF
    PLoS One; 2014; 9(12):e114792. PubMed ID: 25501752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice.
    Chae BS; Shin TY
    Arch Pharm Res; 2007 Feb; 30(2):191-8. PubMed ID: 17366741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
    Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
    Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
    Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
    Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X
    Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.
    Liu X; Jiao Y; Cui B; Gao X; Xu J; Zhao Y
    Lupus; 2016 Oct; 25(11):1180-9. PubMed ID: 27125291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility against Cryptococcus neoformans of lupus mouse models (pristane-induction and FcGRIIb deficiency) is associated with activated macrophage, regardless of genetic background.
    Surawut S; Makjaroen J; Thim-Uam A; Wongphoom J; Palaga T; Pisitkun P; Chindamporn A; Leelahavanichkul A
    J Microbiol; 2019 Jan; 57(1):45-53. PubMed ID: 30456753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
    Abdelhamid L; Cabana-Puig X; Swartwout B; Lee J; Li S; Sun S; Li Y; Ross AC; Cecere TE; LeRoith T; Werre SR; Wang H; Reilly CM; Luo XM
    Front Immunol; 2020; 11():408. PubMed ID: 32265909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on experimental systemic lupus erythematosus mouse model induced by pristane].
    Li JZ; Ding J; Merim B; Li HW; Zhang Y; Shen H; Chen XJ; Wang SJ; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):119-22. PubMed ID: 21315035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.